This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Community Health Systems (CYH) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 130% and 0.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Mednax (MD) Pursues $1.1B Transactions to Reduce Debt Burden
by Zacks Equity Research
Mednax (MD) issues senior notes, and a new revolving credit facility coupled with a term loan remains in place, which is aimed at reducing MD's debt level and associated interest expenses.
Should You Buy Community Health (CYH) Ahead of Earnings?
by Zacks Equity Research
Community Health (CYH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Community Health (CYH) Ties Up to Offer Enhanced Remote Care
by Zacks Equity Research
Community Health (CYH) teams up with Cadence highlighting its aim of utilizing innovative technology to extend enhanced remote care to patients.
Will Patient Days Drive Community Health (CYH) Q4 Earnings?
by Zacks Equity Research
Community Health Systems' (CYH) fourth-quarter results are likely to reflect a higher occupancy rate and average length of stay.
Community Health Systems (CYH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Community Health Systems (CYH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 73.08% and 2.80%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Mednax (MD) Buys Night Lite Pediatrics to Boost Portfolio
by Zacks Equity Research
Mednax (MD) purchases Night Lite Pediatrics, LLC in Orlando to enhance its pediatric business line.
Centene (CNC) Gears Up for Q4 Earnings: What Lies Ahead?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are likely to reflect growth in total membership.
The Zacks Analyst Blog Highlights: Houlihan Lokey, Crocs and Community Health Systems
by Zacks Equity Research
Houlihan Lokey, Crocs and Community Health Systems are highlighted in this Analyst Blog article.
A Window to Buy 3 Great Stocks Ahead of Earnings
by Sejuti Banerjea
Things are coming together for HLI, CROX and CYH.
Retail Loss to Affect Humana's (HUM) Q4 Earnings: Here's How
by Zacks Equity Research
Humana's (HUM) fourth-quarter results are likely to reflect growth in medical membership.
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 results reflect better revenues and a solid contribution from its Government Business and IngenioRx businesses, partly offset by escalating expenses.
Is Community Health Systems (CYH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Community Health Systems (CYH) and LumiraDx Limited (LMDX) have performed compared to their sector so far this year.
Why Fast-paced Mover Community Health Systems (CYH) Is a Great Choice for Value Investors
by Zacks Equity Research
Community Health Systems (CYH) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Best Momentum Stocks to Buy for January 25th
by Zacks Equity Research
PFBC, CYH, and HBNC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 25, 2022
Is a Beat in Store for HCA Healthcare's (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings are likely to have gained from rising admissions and higher revenues.
Community Health (CYH) Unit Declares Pricing of Senior Notes
by Zacks Equity Research
Community Health's (CYH) wholly-owned arm exhibits monetary discretion by pricing senior notes to procure funds.
Why Seasoned Investors are Retaining Community Health (CYH)
by Zacks Equity Research
Community Health Systems (CYH) is focused on making strategic acquisitions to boost its business through inorganic growth.
Encompass Health (EHC) Forms JV, Boosts Presence in Idaho
by Zacks Equity Research
Encompass Health (EHC) forms a JV with Saint Alphonsus for offering better home health and hospice services across Idaho.
The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare
3 Hospital Stocks That Crushed S&P 500 YTD, Set to Rise Further
by Srijita Guha
High patient volumes, mergers and buyouts, and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH.
Encompass Health (EHC) Unveils 40-Bed Hospital Plan in Ohio
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct an inpatient rehabilitation hospital in Ohio, which aims to facilitate improved rehabilitation services throughout the state.
Community Health (CYH) Up 64% YTD: More Growth Potential Left?
by Zacks Equity Research
Community Health Systems' (CYH) cost-control initiatives are likely to lower costs to a great extent and boost the bottom line.
Why Investors Should Hold on to Universal Health (UHS) Stock
by Zacks Equity Research
Universal Health (UHS) can bank on balance sheet strength for future acquisitions to grow its business inorganically.